Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy

Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy

Chemotherapy forms the mainstay of cancer treatment particularly for patients who do not respond to local excision or radiation treatment. However, cancer treatment by drugs is seriously limited by P-glycoprotein (P-gp) associated multi-drug resistance (MDR) in various tumor cells. On the other hand...

Full description

Bibliographic Details
Main Authors:	Tripta Bansal, Manu Jaggi, Roop Khar, Sushama Talegaonkar
Format:	Article
Language:	English
Published:	Canadian Society for Pharmaceutical Sciences 2009-04-01
Series:	Journal of Pharmacy & Pharmaceutical Sciences
Online Access:	https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/4376

Similar Items

P-glycoprotein-dependent pharmacokinetics of irinotecan and its active metabolite, SN-38 in rats: Effect of verapamil
by: Tripta Garg, et al.
Published: (2015-03-01)

Modulation of Flavonoids on P-glycoprotein-mediated Multidrug Resistance
by: Yu-Han Kao, et al.
Published: (2008)

Data of aromatase inhibitors alone and in combination with raloxifene on microarchitecture of lumbar vertebrae and strength test in femoral diaphysis of VCD treated ovotoxic mice
by: Abul Kalam, et al.
Published: (2017-02-01)

Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer-a prospective clinical study
by: Bhatia Ashima, et al.
Published: (2005-09-01)

Pharmacokinetics of Sinomenine in Rats Brain,Blood and Bile, and Its Interaction with P-glycoprotein Modulators, Cytochrome P450 inhibitor, Grapefruit Juice, and Flavonoids
by: Jhy-Wen Wu, et al.
Published: (2001)

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
by: Yusuke Kono, et al.
Published: (2021-03-01)

Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms
by: Ravisha Wadhwa, et al.
Published: (2017-06-01)

Journal of Pharmacy and Bioallied Science
by: Roop K Khar
Published: (2010-01-01)

Evolution of quality control in pharmaceutical technology
by: Roop Krishen Khar
Published: (2013-01-01)

Synthesis of Curcumin Derivatives As Potential P-Glycoprotein Inhibitors
by: Ana Sofia Teixeira Oliveira
Published: (2019)

Overview of P-glycoprotein inhibitors: a rational outlook
by: Kale Mohana Raghava Srivalli, et al.
Published: (2012-09-01)

Marine Natural Products with P-Glycoprotein Inhibitor Properties
by: Dioxelis Lopez, et al.
Published: (2014-01-01)

Synthesis of Curcumin Derivatives As Potential P-Glycoprotein Inhibitors
by: Ana Sofia Teixeira Oliveira
Published: (2015)

Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines
by: S. Mohana, et al.
Published: (2018-11-01)

The nutritional significance of flavonoids
by: Jones, Evan
Published: (1983)

The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression
by: Gao W, et al.
Published: (2014-07-01)

Optimization of dose and route of administration of the P‐glycoprotein inhibitor, valspodar (PSC‐833) and the P‐glycoprotein and breast cancer resistance protein dual‐inhibitor, elacridar (GF120918) as dual infusion in rats
by: Christopher Rowbottom, et al.
Published: (2021-04-01)

Quantitative Structure–Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells
by: Mengmeng Xia, et al.
Published: (2019-04-01)

The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer
by: Li Yan, et al.
Published: (2009-11-01)

Retraction Note: Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines
by: S. Mohana, et al.
Published: (2021-02-01)

P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships
by: Di Pietro A., et al.
Published: (1999-01-01)

Assessment of intestinal permeability of paclitaxel in the presence of NSAIDs and P-glycoprotein inhibitors
by: Zahra Sobhani, et al.
Published: (2017-12-01)

Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs
by: Marika Ruponen, et al.
Published: (2021-01-01)

Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death
by: Joanna Kopecka, et al.
Published: (2020-04-01)

Assessment of intestinal permeability of paclitaxel in the presence of NSAIDs and P-glycoprotein inhibitors
by: Zahra Sobhani, et al.
Published: (2017-11-01)

Multiclass Classifier for P-Glycoprotein Substrates, Inhibitors, and Non-Active Compounds
by: Liadys Mora Lagares, et al.
Published: (2019-05-01)

Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells
by: Yaqiong Zu, et al.
Published: (2014-08-01)

Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir
by: Saleha Rehman, et al.
Published: (2017-01-01)

Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance
by: Sérgio M. Marques, et al.
Published: (2021-03-01)

The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter.
by: Pei-Rong Ding, et al.
Published: (2011-04-01)

Understanding P-glycoprotein mediated multidrug resistance in cancer: new potential targets, biomarkers and molecular inhibitors
by: Vanessa Sofia Lopes Rodrigues
Published: (2019)

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells
by: Qingbin Cui, et al.
Published: (2019-08-01)

Effect of co-treatment of flavonoids with doxorubicin in chemotherapy.
Published: (2001)

The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells
by: Najla O. Zarmouh, et al.
Published: (2020-05-01)

Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.
by: Emma R Job, et al.
Published: (2013-01-01)

Computational Insights into Allosteric Conformational Modulation of P-Glycoprotein by Substrate and Inhibitor Binding
by: Juan Xing, et al.
Published: (2020-12-01)

Using the Variable-Nearest Neighbor Method To Identify P‑Glycoprotein Substrates and Inhibitors
by: Patric Schyman, et al.
Published: (2016-11-01)

The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors
by: Tannock Ian F, et al.
Published: (2009-10-01)

Flavonoid induction of cytochrome P450 (CYP) in human esophageal carcinoma cells: implications for chemotherapy
by: Molepo, Ramaesela Sharon
Published: (2011)

Development of a Novel Quinoline Derivative as a P-Glycoprotein Inhibitor to Reverse Multidrug Resistance in Cancer Cells
by: Yuanyuan Zhou, et al.
Published: (2019-10-01)